Lv730
4380 积分 2022-09-02 加入
Recent advances in genomics and therapeutics in mantle cell lymphoma
7小时前
已完结
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
12小时前
已完结
Efficacy and safety of eltrombopag in combination with dexamethasone as first‐line treatment in adult patients with newly diagnosed immune thrombocytopenia
12小时前
已完结
Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study
1天前
已关闭
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
24天前
已完结
A single-cell atlas of bone marrow B cells reveals defective central B-cell tolerance in immune thrombocytopenia
26天前
已完结
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
1个月前
已完结
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma
1个月前
已关闭
Orelabrutinib and rituximab regimen combined with intravitreal methotrexate for treatment of primary vitreoretinal lymphoma: a case report and literature review
1个月前
已完结
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study
1个月前
已完结
皖公网安备34019202002308
